Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Better outcomes sought for women with CVD
-
- 2014: A year of important advances; challenges ahead Carl J. Pepine, MD, MACC
- Cardiac care outcomes same among rural and urban patients
- Elevated TMAO levels linked to mortality risk in patients with HF
- Many young adults with hypertension fail to receive lifestyle education
- Non–infarct-related artery disease common in patients with STEMI
- Prehospital epinephrine associated with worse outcomes after cardiac arrest
- Rehab-VAD: Cardiac rehabilitation benefited patients with LVADs
- Rosuvastatin failed to reduce fracture risk in JUPITER analysis
-
- Stroke risk lowered with vorapaxar in patients with prior MI, PAD
- TAVR led to encouraging clinical outcomes in bicuspid aortic valve disease
- AUGMENT-HF: Novel implantable device safe, effective in patients with advanced HF
- DEFEAT-HF: Spinal cord stimulation did not benefit patients with HF
- Extended DAPT benefited patients receiving PES
- FACTOR-64: CCTA screening for CAD failed to reduce 4-year events in diabetes patients
- High-dose autologous cell therapy may benefit patients with LV dysfunction after STEMI
- Incidence of infective endocarditis on rise in England
-
- LCZ696 prevented worsening of HF
- Supplemental oxygen increased myocardial injury, infarct size in patients with STEMI
- WOSCOPS: 20-year follow-up demonstrates clinical benefit of statins in men
- Trial Scorecard: AVOID
- Trial Scorecard: BASKET-PROVE II
- Trial Scorecard: DEFEAT-HF
- Trial Scorecard: EASY-FIT
- Trial Scorecard: PROTECT AF
-
- Trial Scorecard: PROTECTION AMI
- Trial Scorecard: Rehab-VAD
- Trial Scorecard: SUPPORT